Financial Summary (All financials)
In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 |
Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 142,059.7 | 169,765.2 |
Revenue growth | | | | | | -100.0% | -16.3% | 18.1% |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 141,438.2 | 167,014.3 |
Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 621.5 | 2,750.9 |
Gross margin | | | | | | | 0.4% | 1.6% |
Selling, general and administrative | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | | |
Sales and marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1,766.7 | 1,875.2 |
Research and development | | | | | | | 293.8 | 193.6 |
General and administrative | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4,843.4 | 2,958.2 |
EBIT | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 135,512.8 | 167,393.0 |
EBIT margin | | | | | | | 95.4% | 98.6% |
Pre-tax income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net margin | | | | | | | 0.0% | 0.0% |
|
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|